GlassScriptPhysician profile
Nathaniel Todnem
NPI 1144584004
$4,133.77
in general payments reported to CMS, 2019-2025
33 companies · $1,584 in 2025
The $1,584 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $783 · 2020: $241 · 2021: $522 · 2022: $205 · 2023: $293 · 2024: $506 · 2025: $1,584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,383.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $1,441.00 | 2019-2025 | Web Aneurysm Embolization System, Sofia 6f-131cm Str, Stent |
| Medtronic, INC. | $897.27 | 2021-2025 | Stealthstation S8 Platform, Strata, Kyphon Express II Kyphopak Tray |
| Penumbra, INC. | $156.46 | 2025 | Red 72 |
| Stryker Corporation | $146.77 | 2022 | |
| Medtronic USA, INC. | $135.16 | 2019-2020 | |
| Silk Road Medical, INC. | $119.24 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Alexion Pharmaceuticals, INC. | $115.34 | 2024 | Ultomiris |
| Catalyst Pharmaceuticals, INC. | $100.12 | 2024-2025 | |
| Abbvie INC. | $92.68 | 2024-2025 | |
| Neurelis, INC. | $90.36 | 2024-2025 | Valtoco |
| Eisai INC. | $77.80 | 2024-2025 | |
| Csl Behring | $76.83 | 2024-2025 | Hizentra, Kcentra |
| Terumo Medical Corporation | $62.09 | 2025 | R2p Misago |
| Takeda Pharmaceuticals U.S.A., INC. | $59.54 | 2024-2025 | Hyqvia |
| Depuy Synthes Sales INC. | $57.44 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $55.41 | 2024-2025 | Rystiggo |
| Novartis Pharmaceuticals Corporation | $50.15 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $45.58 | 2025 | |
| Tg Therapeutics, INC. | $45.57 | 2024-2025 | |
| Lundbeck LLC | $40.75 | 2024-2025 | Vyepti |
| Lemaitre Vascular, INC. | $34.69 | 2019 | |
| Asahi Intecc USA, INC. | $28.98 | 2025 | Asahi Neurology Wires |
| Teva Pharmaceuticals USA, INC. | $26.55 | 2025 | Austedo Xr |
| Octapharma USA, INC. | $23.83 | 2024 | Panzyga |
| Smith+Nephew, INC. | $21.86 | 2025 | Pico 7, Pico 14 |
| Emd Serono, INC. | $21.04 | 2024 | |
| Amgen INC. | $19.62 | 2025 | Uplizna |
| Integra Lifesciences Corporation | $19.09 | 2019 | |
| Argenx US, INC. | $17.97 | 2025 | Vyvgart Hytrulo |
| Imperative Care, INC | $16.51 | 2024 | Zoom 88-T Large Distal Platform |
| Banner Life Sciences, LLC | $15.64 | 2024 | |
| Pfizer INC. | $13.57 | 2025 | |
| Aucta Pharmaceuticals, INC. | $8.86 | 2025 | Motpoly Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Todnem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.